Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 6 |
| List of Tables | 7 | 1 |
| List of Figures | 8 | 2 |
| Introduction | 10 | 1 |
| GBI Research Guidance | 10 | 1 |
| Global Neurology Devices Market Characterization | 11 | 9 |
| Global Neurology Devices Market, Revenue ($m), 2003 2010 | 11 | 1 |
| Global Neurology Devices Market, Revenue Forecast ($m), 2010 2017 | 12 | 1 |
| Global Neurology Devices Market, Key Trends | 13 | 1 |
| Neurostimulation Devices Segment Holds Significant Potential for Venture Capitalists | 13 | 1 |
| Imthera Medial Raises an Additional $0.4m in Venture Financing Round | 13 | 1 |
| MindFrame Secures $3.6m in Financing Round | 13 | 1 |
| Innovative Therapies to be a Mainstay in the Neurology Devices Market | 13 | 1 |
| Robotic Neurosurgery is Improving Accuracy at a Microscopic Level | 14 | 1 |
| Increasing Demand for Minimally Invasive Surgery is Positively Impacting the Interventional Neurology Market | 15 | 1 |
| Global Neurology Devices Market, Market Dynamics | 15 | 1 |
| Market Drivers | 16 | 1 |
| Multiple Indication Potential of Neurology Devices Will Drive Market Growth | 16 | 1 |
| Extensive Marketing Strategies Followed by Neurology Devices Companies will help to Increase Market Share | 16 | 1 |
| Improved Accuracy and Visualization in the Operating Room will Increase Surgeon Adoption Rates for Neurology Devices | 16 | 1 |
| Market Restraints | 17 | 1 |
| Reduction in Medicare Payments for Neurosurgeons to Affect Patients Access to Care Limiting Neurology Devices Market Growth | 17 | 1 |
| High Market Entry Barriers and Government Regulations Restrict Entry for New Players Limiting Market Growth | 17 | 1 |
| High Cost of Devices Acts as a Barrier for Neurology Devices Market Growth | 18 | 1 |
| Global Neurology Devices Market, Key Company Share (%), 2010 | 19 | 1 |
| Global Neurology Devices Market - Category Analysis and Forecasts | 20 | 32 |
| Neurology Devices | 20 | 1 |
| CSF Management | 20 | 1 |
| CSF Management Market, Global, Revenue ($m), 2003 2010 | 21 | 1 |
| CSF Management Market, Global, Revenue Forecast ($m), 2010 2017 | 22 | 1 |
| CSF Management - Market Dynamics | 23 | 1 |
| Market Drivers | 23 | 1 |
| Increased Awareness of Neurological Disorders and Advanced Products will Propel CSF Management Market Growth | 23 | 1 |
| Increase in Number of Hydrocephalus Cases to Drive the Market in the Future | 24 | 1 |
| Market Restraints | 24 | 1 |
| Complications Associated with Hydrocephalus Shunting to Impact Market Growth | 24 | 1 |
| Lack of Specialized Training for Neurology Procedures among Surgeons to Limit Treatment Options, thereby Reducing CSF Management Market Growth | 24 | 1 |
| CSF Management Market, Global, Company Share (%), 2010 | 25 | 1 |
| Neurosurgical Products | 26 | 1 |
| Neurosurgical Products Market, Global, Revenue ($m), 2003 2010 | 26 | 1 |
| Neurosurgical Products Market, Global, Revenue Forecast ($m), 2010 2017 | 27 | 1 |
| Neurosurgical Products Market Dynamics | 28 | 1 |
| Market Drivers | 28 | 1 |
| Growing Demand for Minimally Invasive Procedures to Drive Growth in the Neurosurgical Products Market | 28 | 1 |
| Neuroendoscope Market is Expected to Witness Healthy Growth in the Future Owing to Increased Demand from Pediatric Neurosurgery | 29 | 1 |
| Market Restraints | 29 | 1 |
| Complications and Technical Difficulties in Performing the Procedure and Advent of Ventricular Shunts is Slowing the Neurosurgical Products Market Growth | 29 | 1 |
| Neurosurgical Products Market, Global, Company Share (%), 2010 | 30 | 1 |
| Neurostimulation Devices | 31 | 1 |
| Neurostimulation Devices Market, Global, Revenue ($m), 2003 2010 | 32 | 1 |
| Neurostimulation Devices Market, Global, Revenue Forecasts ($m), 2010 2017 | 33 | 1 |
| Neurostimulation Devices Market Dynamics | 34 | 1 |
| Market Drivers | 35 | 1 |
| Neurostimulation Devices Offers Multi-Indication Potential to Treat Neurological Disorders Giving a Boost to Market Growth | 35 | 1 |
| High Prevalence and Incidence of Neurological Disorders to Drive Market Growth in the Future | 35 | 1 |
| Robust Pipeline in Neurostimulation Devices is Expected to Bring New Products and Drive the Market Growth | 36 | 1 |
| Neurostimulation Devices a more Effective Mode of Treatment for Neurological Disorders than Drugs | 37 | 1 |
| Better Outcomes of Neurostimulation Devices Leading to an Increase in Neurosurgeon Adoption Rates | 37 | 1 |
| Technological Advancements in the Treatment of Parkinson s Disease and the Growing Demand for Alternative Therapies Enhancing Prospects in the Neurostimulation Device Market | 38 | 1 |
| Clinical Data Proving the Efficacy of Neurostimulation Therapy for Chronic Neuropathic Leg and Back Pain Favoring Market Growth | 38 | 1 |
| Market Restraints | 39 | 1 |
| High Cost of Treatment and Lack of Awareness Among the Patient Population about Alternative Treatment Options of Pain is a Major Restraining Factor for Market Growth | 39 | 1 |
| Lack of Skilled Neurosurgeons in Emerging Countries such as India, China and Brazil Reducing Prescription Rates | 39 | 1 |
| Neurostimulation Device Market, Global, Company Shares (%), 2010 | 40 | 2 |
| Interventional Neurology Market, Global, Revenue ($m), 2003 2010 | 42 | 1 |
| Interventional Neurology Market, Global, Revenue Forecasts ($m), 2010 2017 | 43 | 1 |
| Interventional Neurology: Market Dynamics | 44 | 1 |
| Market Drivers | 44 | 1 |
| Increase in Prevalence of Neurovascular Diseased Population to Drive the Interventional Neurology Market | 44 | 1 |
| Increased Safety and Effectiveness Due to Technological Advancements in Embolic System for Treating Cerebral Aneurysms Has Reduced Recurrence and Retreatment Rates | 45 | 1 |
| Market Restraints | 45 | 1 |
| Shortage of Neurosurgeons Trained to use Aneurysm Prevention Devices and Advanced Stroke Limits the Availability of Treatment Options | 45 | 1 |
| Interventional Neurology Market, Global, Company Shares (%), 2010 | 46 | 1 |
| Neurological Diagnostic Equipment Market, Global, Revenue ($m), 2003 2010 | 47 | 1 |
| Neurological Diagnostic Equipment Market, Global, Revenue Forecasts ($m), 2010 2017 | 48 | 1 |
| Neurological Diagnostic Equipment: Market Dynamics | 49 | 1 |
| Market Drivers | 49 | 1 |
| Advancements in Electroencephalography (EEG) Equipment Technology will Drive Future Growth in the Neurological Diagnostic Equipment Market | 49 | 1 |
| Rising Number of Physicians Offices Leading to Additional Sale of EEG and EMG Monitoring Devices | 49 | 1 |
| Rising Incidence of Neurological Disorders Resulting in Significant Growth of the Neurological Diagnostic Equipment Market | 50 | 1 |
| Market Restraints | 50 | 1 |
| Complications Related to the Usage of ICP Monitoring Devices has Limited the Market Growth of Neurological Diagnostic Equipment | 50 | 1 |
| Healthcare Reforms and Cost Containment Measures by Hospitals to Reduce Demand for Neurological Diagnostic Equipment | 51 | 1 |
| Neurological Diagnostic Equipment Market, Global, Company Shares (%), 2010 | 51 | 1 |
| Global Neurology Devices Market - Country Analysis and Forecasts | 52 | 25 |
| Neurology Devices Market: Cross Country Analysis | 52 | 1 |
| Revenue Forecasts, By Country, 2003-2017 | 53 | 1 |
| Neurology Devices Market, the US, Revenue ($m), 2003 2010 | 53 | 1 |
| Neurology Devices Market, the US, Revenue ($m), 2010 2017 | 54 | 1 |
| Neurology Devices Market, Canada, Revenue ($m), 2003 2010 | 55 | 1 |
| Neurology Devices Market, Canada, Revenue ($m), 2010 2017 | 56 | 1 |
| Neurology Devices Market, the UK, Revenue ($m), 2003 2010 | 57 | 1 |
| Neurology Devices Market, the UK, Revenue ($m), 2010 2017 | 58 | 1 |
| Neurology Devices Market, Germany, Revenue ($m), 2003 2010 | 59 | 1 |
| Neurology Devices Market, Germany, Revenue ($m), 2010 2017 | 60 | 1 |
| Neurology Devices Market, France, Revenue ($m), 2003 2010 | 61 | 1 |
| Neurology Devices Market, France, Revenue ($m), 2010 2017 | 62 | 1 |
| Neurology Devices Market, Italy, Revenue ($m), 2003 2010 | 63 | 1 |
| Neurology Devices Market, Italy, Revenue ($m), 2010 2017 | 64 | 1 |
| Neurology Devices Market, Spain, Revenue ($m), 2003 2010 | 65 | 1 |
| Neurology Devices Market, Spain, Revenue ($m), 2010 2017 | 66 | 1 |
| Neurology Devices Market, Japan, Revenue ($m), 2003 2010 | 67 | 1 |
| Neurology Devices Market, Japan, Revenue ($m), 2010 2017 | 68 | 1 |
| Neurology Devices Market, China, Revenue ($m), 2003 2010 | 69 | 1 |
| Neurology Devices Market, China, Revenue ($m), 2010 2017 | 70 | 1 |
| Neurology Devices Market, India, Revenue ($m), 2003 2010 | 71 | 1 |
| Neurology Devices Market, India, Revenue ($m), 2010 2017 | 72 | 1 |
| Neurology Devices Market, Australia, Revenue ($m), 2003 2010 | 73 | 1 |
| Neurology Devices Market, Australia, Revenue ($m), 2010 2017 | 74 | 1 |
| Neurology Devices Market, Brazil, Revenue ($m), 2003 2010 | 75 | 1 |
| Neurology Devices Market, Brazil, Revenue ($m), 2010 2017 | 76 | 1 |
| Global Neurology Devices Market - Competitive Assessment | 77 | 15 |
| Neurology Devices Market Opportunities and Risk Evaluation | 77 | 2 |
| Medtronic, Inc. | 79 | 1 |
| Business Overview | 80 | 1 |
| Key Products | 80 | 2 |
| Boston Scientific Corporation (Neurovascular Portfolio Acquired by Stryker) | 82 | 1 |
| Business Overview | 82 | 1 |
| Key Products | 82 | 2 |
| St. Jude Medical, Inc | 84 | 1 |
| Business Overview | 84 | 1 |
| Key Products | 85 | 1 |
| Integra LifeSciences Holdings Corporation | 86 | 1 |
| Business Overview | 86 | 1 |
| Key Products | 86 | 3 |
| B. Braun Melsungen AG | 89 | 1 |
| Business Overview | 89 | 1 |
| Cadwell Laboratories, Inc. | 90 | 1 |
| Business Overview | 90 | 1 |
| Key Products | 90 | 2 |
| Global Neurology Devices Market - Product Pipeline Analysis | 92 | 16 |
| Neurology Devices - Pipeline Products Summary | 92 | 1 |
| Neurostimulation Devices | 93 | 1 |
| Neurostimulation Devices: List of Pipeline Products | 93 | 5 |
| Neurostimulation Devices: Profiles of Key Pipeline Products | 98 | 1 |
| Vagus Nerve Stimulators | 98 | 1 |
| Deep Brain Stimulators | 98 | 1 |
| Spinal Cord Stimulators | 98 | 1 |
| Sacral Nerve Stimulators | 99 | 1 |
| Other Neurostimulation Devices | 99 | 1 |
| Interventional Neurology | 100 | 1 |
| Interventional Neurology: List of Pipeline Products | 100 | 2 |
| Interventional Neurology: Profiles of Key Pipeline Products | 102 | 1 |
| Embolic Systems | 102 | 1 |
| Navigational Systems | 102 | 1 |
| Other Interventional Neurology Devices | 102 | 1 |
| Neurological Diagnostic Equipment | 103 | 1 |
| Neurological Diagnostic Equipment: List of Pipeline Products | 103 | 2 |
| Neurological Diagnostic Equipment - Profiles of Key Pipeline Products | 105 | 1 |
| Neurosurgical Products | 106 | 1 |
| Neurosurgical Products - List of Pipeline Products | 106 | 1 |
| Neurosurgical Products - Profiles of Key Pipeline Products | 106 | 1 |
| CSF Management | 107 | 1 |
| CSF Management - List of Pipeline Products | 107 | 1 |
| CSF Management - Profiles of Key Pipeline Products | 107 | 1 |
| Global Neurology Devices Market - Consolidation Landscape | 108 | 5 |
| Deals by Count, 2007-2010 | 108 | 2 |
| Key Deals in 2007-2010 | 110 | 1 |
| Johnson &Johnson Completes Acquisition of Micrus Endovascular | 110 | 1 |
| Deal Rationale | 110 | 1 |
| Company Overview | 110 | 1 |
| Covidien Completes Acquisition Of ev3 for $2.6 Billion | 111 | 1 |
| Deal Rationale | 111 | 1 |
| Company Overview | 111 | 1 |
| Medtronic Acquired NDI Medical | 112 | 1 |
| Deal Rationale | 112 | 1 |
| Company Overview | 112 | 1 |
| Appendix | 113 | 6 |
| Definitions | 113 | 3 |
| Neurology Devices | 113 | 1 |
| CSF Management | 113 | 1 |
| Dura Substitutes | 113 | 1 |
| Hydrocephalus Shunts | 113 | 1 |
| Interventional Neurology | 113 | 1 |
| Aneurysm Clips | 113 | 1 |
| Embolic Systems | 113 | 1 |
| Navigational Systems | 114 | 1 |
| Neurovascular Stents | 114 | 1 |
| Neurological Diagnostic Equipment | 114 | 1 |
| Electroencephelograms (EEG) | 114 | 1 |
| Electromyograms (EMG) | 114 | 1 |
| ICP Monitoring Devices | 114 | 1 |
| Neurostimulation Devices | 114 | 1 |
| Cortical Stimulator | 114 | 1 |
| Deep Brain Stimulators | 114 | 1 |
| Sacral Nerve Stimulator | 115 | 1 |
| Spinal Cord Stimulators | 115 | 1 |
| Vagus Nerve Stimulators | 115 | 1 |
| Neurosurgical Products | 115 | 1 |
| Neuroendoscopes | 115 | 1 |
| Neurosurgical Drills | 115 | 1 |
| Acronyms | 115 | 1 |
| Research Methodology | 116 | 2 |
| Secondary Research | 116 | 1 |
| Primary Research | 117 | 1 |
| Modeling and Forecasting | 117 | 1 |
| Contact Us | 117 | 1 |
| Disclaimer | 117 | 1 |
| Sources | 118 | 1 |